INTRODUCTION
Dental implants are an alternative treatment for replacement of missing teeth. To achieve optimum treatment outcome with dental implants, sufficient bone should be available to support and stabilize them. [1, 2] Alveolar bone defects occur due to periodontitis, trauma, tumors, or resorption following tooth extraction and need augmentation before placement of dental implants. [3, 4] Augmentation of atrophic jaws can be performed using autogenous [5] or tissue engineered bone grafts [6, 7] or guided bone regeneration. [8] Autogenous block used as onlay bone graft is considered as the "gold standard" for reconstruction of atrophic ridges. [9, 10] Autogenous grafts can be harvested from intraoral or extraoral donor sites. Intraoral donor sites such as symphysis, lateral ramus, and tuberosity are associated with less morbidity and resorption [11] when compared to extraoral donor sites. [12, 13] However, the larger the defect of the jaw, the greater the need for an extraoral donor site such as the iliac crest, calvarium, and tibia. Autogenous donor site morbidities and limitations [14] such as transient paresthesia, costs, and hospitalization [15, 16] prompted the need for allogenic human bone. Allogenic blocks are categorized based on their preparation process. The preparation process along with sterilization of allografts is performed to reduce immune response and inhibit disease transmission. [17] Fresh frozen bone allografts (FFBAs) induce a stronger immune response compared to freeze-dried bone allografts (FDBA). [18, 19] However, freeze drying decreases the mechanical properties of the bone block. [17, 20] Clinical application of these materials has been reported in some case series. [17, 18] However, successful integration and remodeling of these bone substitutes have been an issue of debate. [21] Although the use of allogenic bone block (ALB) is tempting, treatment outcome in comparison with autogenous bone block (ABB) has never been reviewed to provide scientific evidence for clinical application. Herein, we review survival and success rates of dental implants inserted in ALB and ABB.
MATERIALS AND METHODS

Study design
In the current review, studies that reported treatment outcome of implants (survival/success rates) inserted in augmented alveolar ridges with ABB or ALB in humans were included. Inlay bone grafting was excluded and only onlay use of bone blocks was evaluated. In addition, studies which used growth factors or stem cells in conjugation with bone grafts were excluded. Studies that used various augmentative techniques and did not report implant survival/success rates of onlay bone blocks separately were also excluded. The study design was not a criterion of inclusion for this attentive review and any clinical research was included. Studies on cases with the primary cause of alveolar defect being neoplasm, osteoradionecrosis, or congenital malformations were also excluded.
Search strategy
An electronic search of the literature in PubMed was carried out from January 1990 to June 2014 limited to English language and human studies. The following search terms were used based on PICO model: Patient: Human.
Intervention: AND ("onlay graft*" OR "onlay bone graft*" OR "iliac crest" OR "ilium" OR "allograft bone*" OR "autograft bone*" OR "bone transplant*" OR "block graft*" OR "block bone*" OR "block autograft*" OR "block allograft*" OR "fresh frozen bone*" OR "freeze dried bone*" AND (implant OR implants).
Control: No term was used for the control group to include studies which reported only the results of on technique.
Outcome: AND (survival OR complication* OR failure* OR success*).
Primary selection including screening titles and abstracts was based on the inclusion criteria and full texts of all eligible studies were obtained. The authors reviewed full texts. Searching and screening process was performed by two reviewers independently and any disagreement was discussed by a third reviewer. Among different reports of one experiment, only the latest report, which revealed the most relevant information with respect to the measurements of this review, was included.
Data extraction included implant survival/success rate, treatment complications, and histological evaluations.
Quality assessment
During data extraction, the quality assessment of the included articles was undertaken by the authors according to the following parameters: [22] Proper randomization (yes/no); presence of both control and test groups (yes/no); surgeon blinded to treatment (yes/no/unclear); blindness to outcome (yes/no/unclear); follow-up completion (yes [withdrawal or dropout explanation]/no). Similar to the search process, quality assessment was also done by two reviewers independently and any disagreement was discussed by a third reviewer.
The experiments were then grouped as either low risk of bias (bias unlikely to influence the outcomes) if all criteria were met; medium risk of bias if three or four criteria were met; or high risk of bias (bias that might weakens confidence in results) if three or more criteria were not met.
RESULTS
Electronic search of the literature yielded a total of 635 articles, of which 57 were included [ Figure 1 ]. Thirty-six out of 57 were related to ABB and 23 to ALB. Two studies compared both techniques. [23, 24] Due to the lack of randomized clinical trials and a wide range of study designs, data reporting, recipient site and morphology, defect diameter, graft type, etc., a quantitative outcome measurement could not perform. The results of the literature review (patients and methods, implant survival rate, complication, and histologic evaluation) are presented separately for each type of the bone block.
AUTOGENOUS BONE BLOCK
Patients and methods
Thirty-six studies that fit this category are displayed in Table 1 . Assessing quality of the reviewed publications demonstrated that most of the articles were retrospective studies. Overall, 872 patients who needed alveolar ridge augmentation before implant placement were treated with ABB. Among the studies that reported the type of edentulism, 247 cases were partially edentulous and 205 patients were totally edentulous.
Graft-recipient site was exclusively in the maxilla in 16 studies including 343 patients [12, 23, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] and exclusively in the mandible in nine studies including 145 patients. [15, [39] [40] [41] [42] [43] [44] [45] [46] In three studies (36 patients), only the posterior mandible was reconstructed [15, 41, 42] and in four studies (64 patients) the defects were located in anterior maxillary area. [25] [26] [27] [28] Defects were augmented mostly vertically (height range: 3-10 cm) [28, [39] [40] [41] 15, 44, 46, 47, 55] and horizontal augmentation was performed in fewer patients (width range: 2-6). [23, 25, 29, 42, 48, 49] In ten studies, both horizontal and vertical augmentation had been performed. [12, 26, 31, 32, [34] [35] [36] 51, 53, 55] Intraoral sites (mental symphysis, mandibular body/ramus, and maxillary tuberosity) were the primary source of autogenous bone (362 patients) followed by Iliac crest in 295 patients. The calvarium was the graft source in three studies; [31, 43, 54] however, the number of used calvarial grafts was not reported. The harvested bone was used alone as a block bone graft in 419 patients (48% of the cases). Particulate bone (autogenous, allogenic, or synthetic) was used in combination with block graft in 399 patients. Collagen membrane and titanium mesh were used in 169 and 50 patients, respectively.
Outcome
Implant success and survival rates
The included studies involved insertion of 2,647 implants; of which, 968 were inserted simultaneously with grafts. Survival rates ranging from 73.8% to 100% over 12-192 months were reported in 19 studies. [12, 16, 24, 25, [27] [28] [29] [30] [31] [32] [33] [37] [38] [39] 41, 42, 43, 44, [46] [47] [48] [51] [52] [53] 55] Success rates of 72.8-100% were reported in 12 studies. [23, 26, 29, [34] [35] [36] 40, 41, 15, 43, 45, [47] [48] [49] [50] 52, 54] Criteria for implant success rate were based on Albrektsson et al.'s criteria [56] in nine [29, 15, 43, 47, 49, 50, 52, 54] and Buser et al.'s [57] criteria in two of them. [41, 48] Among studies that only treated maxillary defects, survival and success rates of implants ranged from 73.8% to 100% [12, 25, [27] [28] [29] [30] [31] [32] [33] 37, 38] and 72.8% to 100%, [23, 26, 29, [34] [35] [36] respectively. In studies on the mandible, the corresponding numbers ranged from 90% to 100% [39, 41, 42, 43, 44, 46, 47] and 88.2% to 93.3%, [40, 41, 15, 43, 45] respectively. Survival and success rates of implants inserted in the anterior zone of the maxilla were from 75% to 100% [25, 27, 28] and 81.2%, [26] respectively. In the posterior mandible, the corresponding numbers were 95.6-100% [41, 42] and 89.5-91.1%, [15, 41] respectively. Studies that harvested bone grafts from intraoral sites reported 94.1% to 100% [16, 24, 25, 28, 29, 41, 42, 47, 48, 52, 53, 55] and 81.2% to 100% [26, 29, 41, 15, [47] [48] [49] 52] implant survival and success rates, respectively. The corresponding ranges for extraoral donor sites were 73.8-100% [12, 27, 30, 31, 33, [37] [38] [39] 43, 44, 46] and 72.8-96.1%, [23, [34] [35] [36] 40, 43, 45, 54] respectively.
Complications
Most of the studies did not report complications or stated no major complications. Other studies reported few occurrences of minor complications including peri-implantitis, [37, 39] exposure of the membrane, [55] exposure of the graft, [12, 15, 41, 43, [47] [48] [49] infection, [31, 38, 47] soft tissue dehiscence, [31, 38, 40, 41, 43, 45, 48] hematoma, [27, 33] discomfort, [37, 38] and graft loss. [26, 33, 35] Neurosensory disturbance as a major complication was mostly associated with intraoral donor sites. [40, 41, 45, 48] McGrath et al. [40] and van der Meij et al. [45] reported mental nerve damage in 11.1% and 14.7% of patients, respectively. In a study by Isaksson et al., [37] one patient had neurological disturbances following bone harvesting from the iliac crest.
Histological evaluation
Bone graft integration was histologically evaluated in two studies both using mandibular lateral ramus bone blocks. [24, 29] The nonvital bone was 57.75% [29] and 55.9% [24] of total tissue volume; 27.6% vital bone and 16.4% connective tissue formation were reported by Spin-Neto et al. [24] ALLOGENIC BONE BLOCK
Patients and methods
Twenty-three studies that fit this category are displayed in Table 2 . Assessment of the quality of the reviewed publications demonstrated that most of the articles were case series. Overall, 532 patients who needed alveolar ridge augmentation prior to implant placement were treated by means of ALB. Among the studies reported, the type of edentulism in 209 cases was partially edentulous and only 15 patients were totally edentulous.
The recipient site was exclusively the maxilla in 11 studies (212 patients) [23, [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] and exclusively the mandible in two studies (45 patients) . [68, 69] In one study (24 patients), only the posterior mandible [68] was reconstructed and in two studies (51 patients) the defects were located only in the anterior maxilla. [58, 59] Most defects underwent horizontal augmentation (width range: 2-5 cm) [23, 24, [60] [61] [62] 64, 66, 67, 72, 73, [76] [77] [78] and vertical augmentation was performed in fewer patients (height range: 3-4 cm). [64, 68, 73] In nine studies, both horizontal and vertical augmentations were performed. [58, 59, 63, 66, 68, 72, 73] Different kinds of allograft bone blocks were used. FFBA was the most common type (254 patients) followed by FDBA (94 patients). The block bone was used alone in 210 patients (39.5% of the cases). Particulate bone (allogenic and xenogenic) was applied in combination with block graft in 81 patients. Resorbable/nonresorbable membranes (272 patients), platelet-rich plasma (three patients), [71] or bone marrow aspirate (five patients) [66] was also used.
Outcome
Implant success and survival rates
The included studies involved insertion of 1395 implants; of which, 48 were inserted simultaneously with the graft. Survival rates ranging from 95.3% to 100% over 12-60 months were reported in 19 studies. [24, 58, [60] [61] [62] [63] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] Success rates of 94.7-100% were reported in four of the studies. [23, 59, 63, 64] Criteria for implant success rate were based on Albrektsson et al.'s criteria [56] in three of them [23, 63, 64] while other studies did not mention the success criteria. Among studies that only treated maxillary defects, survival and success rates of implants ranged from 98.3% to 100% [58, [60] [61] [62] [63] [65] [66] [67] and 94.7% to 100%, [23, 59, 63, 64] respectively. In studies on the mandible, the implant survival rate ranged from 95.3% to 100%. [24, [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] No study reported implant success rate in the mandible. Survival of implants inserted in the anterior zone of the maxilla was between 98.8% [58] and 100%. [60] In the posterior mandible, implant survival rate was 95.3%. [68] Complications Most of the studies did not report complications and no major complications were recorded. Other studies reported few occurrences of minor complications including graft exposure, [24, 61, 64, 65, 72] graft loss, [24, 72, 75] soft tissue dehiscence, [59, 70, 75] and infection. [70, 75, 78] Histological evaluation
Bone graft integration was histologically evaluated in 11 studies, [24, 58, 60, 61, 65, 66, 68, 71, 75, 76, 78] mostly revealing incorporation and remodeling of block allograft with no inflammatory response. However, Acocella et al. [60] reported poor cellular activity and poor amounts of newly formed bone with no signs of rapid revascularization of the recipient site. In the cited article, osteoclasts were rarely detected and a mixture of fibrous and new bone formation was observed at the graft recipient site interface in some cases. The presence of a large number of osteocytes trapped within the mineralized matrix, angiogenesis, and few osteonic structures was reported by Orsini et al. [61] The amount of nonvital bone, vital bone, and soft tissue ranged from 26% to 61.96%, 8.4% to 44%, and 27% to 48.4%, respectively. [24, 58, 60, 61, 66, 68] The new bone presented features of mainly woven and lamellar bone with large marrow spaces. [60, 75] 
QUALITY ASSESSMENT
Estimated risk of bias for each study is reported in Table 3 that shows that almost all included studies had a high risk of bias.
DISCUSSION
Autogenous onlay grafts are considered the gold standard treatment for alveolar defects. Systematic reviews on survival rates for dental implants in ABB augmented alveolar ridges showed various study designs. [79, 80] Due to limitations of ABB, onlay grafting with allogenic blocks has been recently evaluated. However, reviews on ALB reported a lack of evidence for the establishment of its treatment efficacy. [81, 82] The current review compared implant treatment outcomes between ABB and ALB. Most biocompatible substitutes can be integrated into the host bone due to minimal inflammatory response, but only the remodeled tissue can be named a successful bone graft. The normal remodeling process of the jaw usually takes more than 12 months. [4] [61] CS Corticocancellous Keith et al. [75] reported implant survival rate of 99% when only seven out of 82 ALBs failed. Duration of follow-up was not mentioned for three ABB [24, 50, 55] and five ALB groups. [24, 64, 66, 77, 78] Wallace and Gellin [62] had reported 4 months follow-up. Carinci et al. [63] showed that cumulative implant success rate decreased from 96% in the 1 st year to 40% in 4 years due to crestal bone loss. Follow-ups for ALB were relatively shorter than ABB (12-192 months vs. 12-60 months).
The resorption rate of ALB was three times more than that of ABB at 6 months. [83] Occlusal force or accumulation of microbial plaque may cause micro-fractures in a nonremodelable bone block and cause weakness in maintaining crestal bone around dental implants. [84] Deluiz et al. [78] demonstrated that significantly different resorption rates of allografts occur during 4-8 months of healing.
ABB harvested from intraoral donor sites showed higher implant survival than extraoral donor sites (94.1-100% [16, 24, 25, 28, 29, 41, 42, 47, 48, 52, 53, 55] vs. 73.8-100%). [12, 27, 30, 31, 33, [37] [38] [39] 44, 45, 47] In this group, implants placed in reconstructed mandibles survived longer than implants in reconstructed maxillae (90-100% [39, 41, 42, 43, 44, 46, 47] vs. 73.8-100%). [12, 25, [27] [28] [29] [30] [31] [32] [33] 37, 38] Simultaneous implant placement had a frequency higher than 36% in ABB groups. Survival of simultaneously placed dental implants was higher than those placed in ALB after a healing period (93.7% vs. 98.6%). [74] Peñarrocha-Diago et al. [48] reported 98.5% survival rate for both delayed and simultaneously inserted implants in autografts harvested from intraoral sites.
Recipient site analysis and matching is an important variable in the interpretation of results of augmentative techniques. ALB was mostly used for horizontal bone augmentation or defects limited to one or two teeth. No report of ALB could be found in the treatment of posterior mandible in our review; most were found in the anterior maxilla. Graft resorption occurred more in the mandible than in the maxilla. [52] Dimension and location of the recipient site influence treatment outcomes. [85] Particulate bone with collagen membrane has been used with ALB in comparison to ABB (48% vs. 39.5%). The addition of PRP to ALB resulted in 100% survival of implants. [71] Two trials compared implant treatment outcomes between ALB and ABB. [23, 24] Horizontal augmentation of defects <4 mm width resulted in 100% implant survival rate for both techniques. [24] Five-year follow-up of the horizontal augmentation of the maxilla revealed 96.1% and 98.7% success rates for implants inserted in ABB and ALB, respectively. [23] Low incidence of complications related to onlay bone grafting was observed in both techniques. Paresthesia was mostly transient and related to intraoral donor sites. [40, 41, 45, 48] In addition, pain and discomfort were reported in few studies following block harvesting from the iliac crest. [37, 38] Histological evaluation in two articles revealed that more than half of the tissue volume was nonvital graft remnants. [24, 29] Acocella et al. [29] demonstrated reduction of nonvital bone and final remodeling with time. A wide range of remodeling has been reported (8.4% [24] to 44% [68] ). While most studies revealed proper integration of ALB, some studies reported no regenerative and remodeling activity with a high percentage of nonvital bone. [24, 60] Formation of fibrous tissue, which was reported in some cases at the graft recipient site interface, could reduce graft survival. [60] Goldberg and Stevenson [86] mentioned delayed vascularization of ALB and longer implant healing periods.
Comparing histological integration of ABB and ALB, Spin-Neto et al. [24] reported that larger amounts of both nonvital and vital bone and lesser amounts of soft connective tissue were observed in the ABB group. No difference was observed between the groups in either bone-to-implant contact or the bone area between implant threads. [24] 
CONCLUSION
Due to the lack of controlled clinical trials, a definite consensus cannot be reached regarding the success and survival of implants placed in defects reconstructed with autogenic versus ALB. Wide ranges of implant success and survival have been reported for both techniques. The main concern regarding ABB is donor site complications and for ALB is the integration of the graft. Future studies with longer follow-ups are required to further elucidate these issues.
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